NCT01495390View on ClinicalTrials.gov

A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers

CompletedOBSERVATIONAL
Enrollment

139

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Amyotrophic Lateral SclerosisNervous System DiseasesSclerosisMotor Neuron DiseaseSpinal Cord DiseasesCentral Nervous System DiseasesNeurodegenerative DiseasesNeuromuscular DiseasesALS
Trial Locations (6)

15213

University of Pittsburgh, Pittsburgh

30322

Emory University, Atlanta

32224

Mayo Clinic Jacksonville, Jacksonville

85013

Barrow Neurological Institute, Phoenix

02114

Massachusetts General Hospital, Boston

01655

University of Massachusetts Medical Center, Worcester

All Listed Sponsors
collaborator

ALS Association

OTHER

collaborator

ALS Finding a Cure

OTHER

lead

Massachusetts General Hospital

OTHER

NCT01495390 - A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers | Biotech Hunter | Biotech Hunter